Barclays Sticks to Their Hold Rating for Waters Corp (WAT)

In a report released yesterday, Jack Meehan from Barclays maintained a Hold rating on Waters Corp (WAT), with a price target of $218. The company’s shares closed yesterday at $240.71, close to its 52-week high of $255.21.

According to TipRanks.com, Meehan is a 4-star analyst with an average return of 6.9% and a 62.1% success rate. Meehan covers the Healthcare sector, focusing on stocks such as Bio-Rad Laboratories, PRA Health Sciences, and IQVIA Holdings Inc.

Waters Corp has an analyst consensus of Moderate Buy, with a price target consensus of $229.67.

See today’s analyst top recommended stocks >>

Based on Waters Corp’s latest earnings release for the quarter ending December 31, the company reported a quarterly net profit of $185 million. In comparison, last year the company had a net profit of $112 million.

Based on the recent corporate insider activity of 47 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Waters Corp. is a measurement company, which engages in the analytical workflow solutions involving liquid chromatography, mass spectrometry and thermal analysis innovations. It operates through Waters and TA segments.